Armata Pharmaceuticals, Inc. ARMP
AMEX · United States · Health Technology
$3.52+0.21 (+6.34%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.27 | -0.45 | +39.3% | $2.51M | +527.5% | +13.4%$4.25→$4.82 |
| Q1 2026 | 2026-05-13 | -0.39 | — | — | — | — | -8.9%$9.00→$8.20 |
| Q4 2025 | 2026-03-25 | -0.36 | -0.19 | -89.5% | — | — | +13.9%$8.21→$9.35 |
| Q3 2025 | 2025-11-12 | -0.42 | -0.42 | 0.0% | — | — | -5.5%$6.75→$6.38 |
| Q4 2024 | 2025-03-20 | -0.23 | -0.35 | +34.3% | — | — | — |
| Q4 2023 | 2024-03-21 | -0.30 | -0.34 | +11.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.